← The Wire
ARCTNasdaq
Arcturus Therapeutics Holdings Inc.
Pharmaceutical Preparations · DE · CIK 1768224
Develops liver and respiratory rare disease therapeutics and vaccines using messenger RNA technology
red 8-K · 90d
$198M
Market cap
$6.82
Last close
-0.9%
1D
-5.7%
5D
395K
Volume
Price · last 39 sessions-20.4%
May 4L $6.69 · H $9.22Jun 29
159
Total filings
Jun 5, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 5, 202610-Q10-QMay 7, 20268-KExecutive Change · Results of OperationsMay 7, 2026DEF 14ADEF 14AApr 24, 202610-K10-KMar 3, 20268-KResults of OperationsMar 3, 20268-KExecutive ChangeDec 15, 202510-Q10-QNov 12, 20258-KResults of OperationsNov 10, 20258-KReg FD Disclosure · Company UpdateOct 22, 20258-KReg FD DisclosureSep 26, 20258-KReg FD DisclosureAug 29, 202510-Q10-QAug 11, 20258-KResults of OperationsAug 11, 20258-KReg FD DisclosureJun 30, 20258-KShareholder VoteJun 6, 202510-Q10-QMay 12, 20258-KResults of OperationsMay 12, 2025DEF 14ADEF 14AApr 25, 202510-K10-KMar 6, 20258-KResults of OperationsMar 6, 2025SC 13GSC 13GNov 8, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 2024SC 13GSC 13GNov 5, 20248-KReg FD DisclosureAug 13, 202410-Q10-QAug 5, 20248-KResults of OperationsAug 5, 20248-KExecutive Change · Reg FD DisclosureJun 24, 20248-KExecutive Change · Shareholder VoteJun 14, 202410-Q10-QMay 8, 20248-KResults of OperationsMay 8, 2024DEF 14ADEF 14AApr 29, 20248-KAuditor ChangeApr 5, 20248-KReg FD DisclosureMar 19, 202410-K10-KMar 14, 20248-K/AResults of OperationsMar 14, 20248-KResults of OperationsMar 7, 20248-KExecutive ChangeFeb 23, 202410-Q10-QNov 14, 20238-KResults of OperationsNov 14, 20238-KMaterial Agreement · Company UpdateSep 26, 20238-KMaterial Agreement · Company UpdateAug 14, 202310-Q10-QAug 7, 20238-KResults of Operations · Company UpdateAug 7, 2023424B5424B5Aug 7, 20238-KReg FD DisclosureJul 14, 20238-KReg FD DisclosureJun 30, 20238-KShareholder VoteJun 16, 202310-Q10-QMay 9, 20238-KResults of OperationsMay 9, 2023DEF 14ADEF 14AMay 1, 20238-KReg FD DisclosureApr 28, 20238-KMaterial Agreement · New Debt / ObligationApr 21, 20238-KReg FD DisclosureApr 11, 202310-K10-KMar 29, 20238-KResults of OperationsMar 28, 20238-KAgreement TerminatedMar 17, 2023SC 13GSCHEDULE 13GFeb 9, 20238-KExecutive Change · Reg FD DisclosureDec 13, 20228-KReg FD DisclosureDec 13, 202210-Q10-QNov 9, 20228-KResults of OperationsNov 9, 20228-KMaterial Agreement · Agreement TerminatedNov 4, 20228-KMaterial AgreementNov 2, 20228-KMaterial AgreementSep 1, 202210-Q10-QAug 9, 20228-KResults of OperationsAug 9, 20228-KMaterial Agreement · Shareholder VoteJun 24, 202210-Q10-QMay 9, 20228-KResults of OperationsMay 9, 2022DEF 14ADEF 14AMay 2, 20228-KMaterial Agreement · Agreement TerminatedApr 20, 202210-K10-KMar 1, 20228-KResults of OperationsFeb 28, 20228-KCompany UpdateFeb 17, 2022SC 13GSC 13GFeb 15, 2022SC 13GSC13GFeb 14, 20228-KExecutive ChangeFeb 11, 2022SC 13GSC 13GFeb 11, 2022
In the News
Coverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance